CP diseases

Focus on assessment information applied to lung diseases.
Differentiate between two major groups of lung diseases:
- Obstructive lung diseases: Limited airflow, primarily issues in the bronchial tubes.
- Restrictive lung diseases: Limited lung volume, affecting the pleural space, chest wall, interstitium, or alveoli.
Pathophysiology impacts assessment findings.

Affects pleural space, chest wall, interstitium, and alveoli.
Classified by low inspiratory volumes; difficulty inhaling full tidal volume.
- Examples of the restrictive nature:
- Challenges in taking deep breaths consistently.
- Low compliance due to inability to fill lungs.

Obstructive Lung Diseases:
- Characterized by low expiratory flows.
- Harder to breathe out (exhale).
- Patients often feel breathless but attribute it to difficulty inhaling due to trapped air.
Restrictive Lung Diseases:
- Characterized by low inspiratory volumes.
- Difficulties in inhalation, but easier to exhale.
- Compliance issues are prevalent.

Etiology: Refers to the cause or origin of a disease.
Pathophysiology: Problematic changes in the lung, differentiating it from normal function.
Manifestations: Signs and symptoms exhibited by the patient.
Assessment focus will be on chest examination and how it ties back to etiology and pathophysiology.

Mnemonic: CBABE (Cystic fibrosis, Bronchiectasis, Asthma, Chronic bronchitis, Emphysema)
COPD: Chronic Obstructive Pulmonary Disease
- Combination of emphysema and chronic bronchitis.
- Commonly related to smoking as the primary causal factor.
- Difficulties arise in distinguishing contributions of emphysema vs. chronic bronchitis in symptomatic patients.
- Often underdiagnosed, symptoms can emerge years post smoking cessation.
- Diagnosed through pulmonary function tests (spirometry).

Defined as chronic inflammation of the bronchi.
- Characterized by a chronic productive cough lasting 3 months each year for two consecutive years.
Common causes:
- Primarily smoking.
- Can also occur from chronic infections and indoor air pollution.
Pathophysiology:
- Excessive bronchial secretions, bronchospasm, chronic inflammation of peripheral airways.
- Complications include mucus plugging and possible atelectasis.
Manifestations:
- Overweight individuals, known as the "blue bloater."
- Chronic cough with copious yellow-green sputum, which can change throughout the day.
- Cyanosis and digital clubbing in later stages due to hypoxemia.

Characterized by weakening and destruction of alveolar walls and alveolar-capillary membranes.
- Results in decreased surface area for gas exchange.
Etiology:
- Most commonly, smoking, but also occupational exposure to dust and chemicals, and alpha-1 antitrypsin deficiency.
Pathophysiology:
- Over-distended alveoli (blebs or bullae) that lead to hypoxemia.
- Presents with airway collapse and air trapping.
Manifestations:
- Known as the "pink puffer" due to barrel chest and muscle wasting from labored breathing.
- Limited sputum production and hypoxemia without cyanosis.
- Hypercapnia due to ineffective ventilation.

Defined by hyperreactivity of the bronchial airways leading to bronchospasm and airway inflammation.
- Known as reactive airway disease.
Etiology involves hypersensitivity to triggers (e.g., allergens).
Key characteristic: Reversible bronchospasm, easy response to bronchodilators.
Manifestations:
- Notable wheezing, coughing, and chest tightness during exacerbations.
- Bronchial secretions are thick, have mucoid appearance, and come in small amounts.
Chronic disease that requires good management to prevent progression to chronic conditions like COPD.

Defined as chronic dilation and distortion of bronchi or bronchioles.
- Can be localized to one lobe or multiple lobes.
Etiology: Prolonged recurrent infections or exposure to heavy chemical irritants.
Symptoms:
- Productive cough with large, thick sputum production.
- Color may be purulent, often brown due to blood from broken vessels.
Management focuses on symptom control; often requires antibiotics and airway clearance.

Genetic disorder characterized by thick and sticky mucus, affecting the lungs and pancreas.
- Lungs accumulate large amounts of viscous secretions.
Pathophysiology:
- Chronic bronchial secretions lead to lung infections and nutritional absorption issues.
- Patients may present with malnutrition due to pancreatic insufficiency.
Management:
- Frequent lung infections are common, with no known cure but treatments available (e.g., CRISPR technology).
- Symptoms include clubbing and possible hyperinflation similar to emphysema patients, but they may be of a smaller stature due to their difficulty absorbing nutrients.

Next steps involve deep dives into specific pathophysiology of each condition, utilizing chest assessments to identify symptoms.
Students should prepare for upcoming lessons with more detailed exploration of pulmonary function tests.